Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BYJournal of Medicinal Chemistry

Cyclic Peptides in Modern Drug Discovery: Trends and Therapeutic Directions

  1. 1ACS International Pvt. Ltd. , ,
  2. 2CAS, A Division of the American Chemical Society , , ,

Abstract

Peptide therapeutics are an important drug modality due to their high specificity, favorable safety, and expanding design potential. Among them, cyclic peptides occupy a space between small molecules and biologics, offering improved rigidity, stability, and target engagement. This report analyzes trends in cyclic peptide research using data from the CAS Content Collection over the past two decades. Results show a steady rise in academic publications and patents, reflecting growing interest across discovery and development. Notably, oral administration is gaining attention, indicating progress toward addressing long-standing bioavailability challenges. Beyond delivery, we examine how peptide and cyclization types, along with specific chemical modifications, relate to administration routes, therapeutic indications, and molecular targets. We also assess physicochemical properties to understand how molecular features influence developability. Together, these insights provide a comprehensive view of the evolving cyclic peptide landscape and emerging principles guiding their future development.

Related

  1. Generation of membrane-permeable cyclic peptides inhibiting protein–protein interaction
    Xinjian Ji, Lluc Farrera Soler, Jiajun Li +9
    Nature Chemical BiologyPeer-reviewedCC BY7 citedMolecular biology & gene regulationOrganic chemistryOpenAlex
  2. Integration of Acoustic Ejection Mass Spectrometry Enables Efficient High Throughput Purification Workflow for Peptides in Discovery Space
    Erwin G. Abucayon, Mengyu Xu, Tao Meng +8
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
  3. ROLE OF HETEROCYCLIC SCAFFOLDS IN MODERN DRUG DESIGN: STRUCTURE–ACTIVITY RELATIONSHIPS, THERAPEUTIC APPLICATIONS AND EMERGING COMPUTATIONAL APPROACHES
    Brijesh Kumar, Anchal Shukla, Brijesh Jaiswal
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
  4. The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development
    Harrison G. Zhang, Peter Eckmann, Jiacheng Miao +2
    SciencePeer-reviewedLicence not stated16 citedMedicinal chemistry & drug discoveryOpenAlex
  5. Mechanism-driven nano-therapeutic platform integrating plant-derived compounds and membrane-active peptides reprograms inflammatory, cell cycle arrest, cGAS–STING, and apoptotic gene expression to quench colorectal cancer
    Doaa Ibrahim, Safaa I. Khater, Ahmed Abdelfattah-Hassan +9
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textMaterials & polymersCrossref
BibTeX
@article{thite2026cyclic,
  title = {{Cyclic Peptides in Modern Drug Discovery: Trends and Therapeutic Directions}},
  author = {Trupti Thite and Kavita A. Iyer and Preeti Jain and Janet M. Sasso and Rumiana Tenchov and Sudarshan Murmu and Mahaveer Surendranath and Ankush Maind and Umesh Balande and Qiongqiong Angela Zhou},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  month = jul,
  doi = {10.1021/acs.jmedchem.6c01522},
  url = {https://doi.org/10.1021/acs.jmedchem.6c01522},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Cyclic Peptides in Modern Drug Discovery: Trends and Therapeutic Directions
AU  - Trupti Thite
AU  - Kavita A. Iyer
AU  - Preeti Jain
AU  - Janet M. Sasso
AU  - Rumiana Tenchov
AU  - Sudarshan Murmu
AU  - Mahaveer Surendranath
AU  - Ankush Maind
AU  - Umesh Balande
AU  - Qiongqiong Angela Zhou
PY  - 2026
DA  - 2026/07/21
JO  - Journal of Medicinal Chemistry
DO  - 10.1021/acs.jmedchem.6c01522
UR  - https://doi.org/10.1021/acs.jmedchem.6c01522
AB  - Peptide therapeutics are an important drug modality due to their high specificity, favorable safety, and expanding design potential. Among them, cyclic peptides occupy a space between small molecules and biologics, offering improved rigidity, stability, and target engagement. This report analyzes trends in cyclic peptide research using data from the CAS Content Collection over the past two decades. Results show a steady rise in academic publications and patents, reflecting growing interest across discovery and development. Notably, oral administration is gaining attention, indicating progress toward addressing long-standing bioavailability challenges. Beyond delivery, we examine how peptide and cyclization types, along with specific chemical modifications, relate to administration routes, therapeutic indications, and molecular targets. We also assess physicochemical properties to understand how molecular features influence developability. Together, these insights provide a comprehensive view of the evolving cyclic peptide landscape and emerging principles guiding their future development.
SN  - 0022-2623
SN  - 1520-4804
ER  -